XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 1,309.5 $ 1,337.8 $ 2,619.2 $ 2,660.4
Cost of sales [1] 501.6 510.3 1,013.0 1,017.7
Gross profit 807.9 827.5 1,606.2 1,642.7
Research and development [1] 199.8 219.8 397.8 438.9
Selling, general and administrative [1] 144.7 172.3 291.0 340.2
Amortization of acquired intangible assets 232.9 248.2 468.3 496.7
Special charges and other, net 4.3 3.6 4.6 11.7
Operating expenses 581.7 643.9 1,161.7 1,287.5
Operating income 226.2 183.6 444.5 355.2
Other income (expense):        
Interest income 0.3 1.0 0.6 1.7
Interest expense (93.3) (129.6) (192.4) (262.2)
Loss on settlement of debt (45.1) (0.1) (71.9) (2.0)
Other income (loss), net 0.7 (1.4) (2.5) 1.3
Income before income taxes 88.8 53.5 178.3 94.0
Income tax provision (benefit) 15.2 (55.4) (18.9) (65.6)
Net income $ 73.6 $ 108.9 $ 197.2 $ 159.6
Basic net income per common share (in dollars per share) $ 0.29 $ 0.46 $ 0.78 $ 0.67
Diluted net income per common share (in dollars per share) 0.27 0.43 0.75 0.63
Dividends declared per common share (in dollars per share) $ 0.3680 $ 0.3660 $ 0.7355 $ 0.7315
Basic common shares outstanding (in shares) 256.0 238.4 251.9 238.1
Diluted common shares outstanding (in shares) 267.7 255.3 262.8 254.6
[1]
(1) Includes share-based compensation expense as follows:
Cost of sales$6.0 $5.2 $12.4 $10.1 
Research and development$24.5 $22.3 $45.0 $41.8 
Selling, general and administrative$19.2 $17.8 $34.7 $34.1